K
KnowMBAAdvisory
Industry brief·Clinical Trials Operations

AI and operations consulting for clinical trials operations

AI, automation, and operations consulting for clinical-trial sponsors, CROs, and site networks. Solve patient recruitment, regulatory-and-protocol velocity, and the operating model that determines whether the trial reads out on time and on budget.

🎯

Best fit

Heads of clinical operations, CROs, sponsor study leads, site-network operators, and digital-trial leaders at biopharma sponsors, contract research organizations, and clinical-site networks.

What's hurting

Signs you need this in Clinical Trials Operations.

The operational tells we hear most often when teams in this industry reach out for a diagnostic.

Patient recruitment is the single biggest cause of trial delay; sites enroll well below plan and the sponsor cost-of-delay runs into seven-figures-per-day on Phase III studies.

Protocol amendments are frequent, expensive, and operationally disruptive — every amendment ripples through CTMS, EDC, eConsent, and site training.

Regulatory and quality discipline (GCP, ICH, 21 CFR Part 11, EU CTR) is non-negotiable and the audit-and-evidence workflow is sustained.

Site activation cycles are long; the time from contract-and-budget execution to first-patient-in is the operational bottleneck nobody loves.

Decentralized and hybrid trial models reshape the operating model — site, sponsor, vendor, and patient relationships all need redesign.

Data-monitoring, safety-signal detection, and pharmacovigilance workflows are data-intensive and the cost-and-risk profile is shifting with AI.

Where AI delivers

AI opportunities for Clinical Trials Operations.

Specific, scoped use cases where AI and automation move the needle in this industry — not generic LLM hype.

01

Patient-recruitment AI — site-and-cohort identification, EHR-and-claims-based outreach, and pre-screening automation.

02

Protocol-design and amendment-impact AI — protocol complexity scoring, amendment-impact simulation, and operational-feasibility prediction.

03

Site-activation acceleration AI — contract-and-budget templating, regulatory-document automation, and the activation-cycle bottleneck workflow.

04

EDC, source-data verification, and data-cleaning AI — query-volume reduction and data-cleaning velocity.

05

Safety-signal-detection and pharmacovigilance AI — adverse-event detection, narrative summarization, and ICSR-processing automation.

06

Decentralized-and-hybrid-trial AI — eConsent, ePRO, remote-monitoring, and home-visit operating workflow.

Where we focus

Transformation themes

The structural shifts we keep seeing in this industry. Most engagements touch two or three of these at once.

Patient-recruitment operating model — site-and-cohort selection, outreach, and pre-screening as a single integrated discipline.

Protocol-design and amendment discipline — the upstream work that prevents the downstream operational disruption.

Site-activation cycle — the contract, budget, regulatory, and IRB workflow that determines time-to-first-patient.

Decentralized and hybrid trial operating model — the redesign across site, sponsor, vendor, and patient relationships.

Data, monitoring, and safety operating model — the EDC, source-data-verification, and pharmacovigilance discipline.

Regulatory and quality framework — the GCP, ICH, 21 CFR Part 11, EU CTR operating capability as a sustained discipline.

Methodology

Concepts that matter most in Clinical Trials Operations.

The frameworks and operating concepts we lean on most when working with teams in this industry.

What we ship

Services for Clinical Trials Operations.

The engagement shapes that fit this industry's reality. Each one ends with a working system, not a deck.

Free diagnostics

Run a free diagnostic

ai readiness auditdigital transformation auditsupplier cost audit

Proof

Real cases in Clinical Trials Operations.

What this looks like when it works — operators who applied the same patterns and the lessons that survived contact with reality.

🧬

IQVIA

ongoing

IQVIA is one of the largest global clinical-research organizations and healthcare-data-and-analytics providers, with an integrated operating model spanning CRO services (clinical trial design, execution, monitoring, and analytics), real-world-data and evidence services, and the underlying data-and-technology platform. The company is consistently cited as a defining example of the integrated CRO-and-data operating model and has continued sustained investment in AI-and-analytics capabilities across the trial lifecycle.

One of the largest global CROs and healthcare-data-and-analytics providers (publicly disclosed)
Operating scope
CRO services, real-world-data, evidence services, and the underlying data-and-technology platform (publicly disclosed)
Integrated operating model
Sustained AI-and-analytics investment across the trial lifecycle (publicly disclosed)
Technology investment

Lesson

Modern CRO economics are won by the integration of clinical-trial execution with the real-world-data and analytics operating model. The CROs that build the integrated data-and-trial platform compound; the standalone CROs compete on cost-and-throughput against the integrated operators with a structural data advantage.

🟪

Medidata (Dassault Systèmes)

ongoing

Medidata is one of the leading clinical-trial technology platforms (EDC, CTMS, eConsent, ePRO, RTSM, decentralized-trial workflow, AI-and-analytics) operating as part of Dassault Systèmes' life-sciences platform. The company is consistently cited as a defining example of the integrated clinical-trial-technology operating model and has continued sustained investment in AI-and-analytics capabilities across the trial-execution stack.

Integrated EDC, CTMS, eConsent, ePRO, RTSM, decentralized-trial, and AI-and-analytics platform (publicly disclosed)
Platform scope
Operating as part of Dassault Systèmes' life-sciences platform (publicly disclosed)
Operating model
One of the leading clinical-trial-technology platforms (publicly disclosed)
Industry positioning

Lesson

Clinical-trial-technology operating economics are won by integrating the trial-execution stack across EDC, CTMS, eConsent, ePRO, and decentralized-trial capabilities with the AI-and-analytics layer. The platforms that build the integrated stack compound the sponsor-and-CRO contract base; the point-tool vendors get displaced as the integrated platforms expand the surface area.

🔬

Hypothetical: mid-size sponsor clinical operations group

2024-2025

A mid-size biopharma sponsor running 18 active clinical trials across Phase II and III was carrying a 41% rate of sites enrolling below 50% of plan, a site-activation cycle averaging 9.2 months from contract execution to first-patient-in, and a protocol-amendment cycle that consumed two FTEs per amendment per study. We deployed a site-and-cohort selection AI on EHR-and-claims data, automated the site-activation document-and-regulatory workflow, and built a protocol-amendment impact-simulation tool that flagged operational disruption upstream. The under-enrolling-site share dropped, site-activation collapsed, and amendment-cycle FTE load halved.

41% → 22%
Sites enrolling below 50% of plan
9.2 months → 5.4 months
Site-activation cycle (contract-to-FPI)
2 FTEs per amendment → 1 FTE per amendment
Protocol-amendment FTE load

Lesson

Clinical-trial operating economics are won by the integration of patient-recruitment, site-activation, and protocol-amendment discipline. The sponsors that try to fix one of the three in isolation see point gains; the ones that wire the integrated operating model compound the time-to-readout and the cost-of-delay economics.

Start a project for
clinical trials operations.

Share the industry-specific bottleneck and the desired outcome. KnowMBA will scope the right audit, sprint, or build from there.

Start a ProjectBrowse services

Typical response time: 24h · No retainer required